Stocktoria
RetinalGenix Technologies Inc. RTGN
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-01-07
RetinalGenix Technologies Inc. (RTGN) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend.
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Market cap$75M
How it ranks in Manufacturing · percentile among 1829 companies
Piotroski Fstronger than 26%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| RTGN | RetinalGenix Technologies Inc. | 3/9 | — | — | — |
| MDLN | Medline Inc. | 6/9 | 2.84 | 44.1 | +11.5% |
| SYK | STRYKER CORP | 4/9 | 3.96 | 39.3 | +11.2% |
| MMM | 3M CO | 5/9 | 5.46 | 26.3 | +1.5% |
| BDX | BECTON DICKINSON & CO | 6/9 | 2.29 | 25.6 | +8.2% |
| BSX | BOSTON SCIENTIFIC CORP | 4/9 | 2.81 | — | +19.9% |
| BAX | BAXTER INTERNATIONAL INC | 5/9 | 3.86 | — | +5.7% |
FAQ
Is RTGN financially healthy?
RetinalGenix Technologies Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does RTGN pay a dividend?
No, RetinalGenix Technologies Inc. does not currently pay a dividend.
Source: SEC EDGAR filings · CIK 0001836295 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.